摘要
目的探讨阿托品和复方托品卡胺在儿童散瞳验光中的对比应用,分析复方托品卡胺在临床应用中的优势与不足。方法选40例(80只眼)屈光不正儿童和青少年患者,按年龄分作4～12岁儿童组和12～16岁青少年组,每组各20例(40只眼)。分别采取自身对照方法,均先用复方托品卡胺散瞳,然后用TOPCON MR-8800电脑验光检查屈光度;第二天再用1%阿托品眼膏涂眼每日3次,连用3d后再用同一电脑验光仪检测作为自身对照,分别记录两组用不同药物散瞳验光的屈光度数。结果在儿童组,复方托品卡胺散瞳后球镜屈光度均值及阿托品比较差异有显著性;柱镜均值及轴向均值与阿托品比较差异无显著性;在青少年组,复方托品卡胺散瞳后球镜均值与阿托品比较差异无显著性;柱镜均值与轴向均值与阿托品比较差异亦无显著性。结论 12岁以下儿童屈光不正检测散瞳中复方托品卡胺仍不能取代阿托品,但对儿童的散光检测,弱视、眼底病检查提供了方便。12岁以上的青少年屈光不正检测散瞳中复方托品卡胺可以取代阿托品,以达到验光后快速恢复调节能力的目的。
Objective To explore the practical value of compound tropicamide in children with refraction error.Methods 40 children（80 eyes） with refraction error were divided into two groups according to the age,one group of 4-12 years old and the other group of 12-16 years old.Compound tropicamide was used to disperse pupil.And optometry was performed by computer with T0PC0N MR-8800 unit.After that,atropine gutta was applied three times daily for three days.And optometry was conducted by the same computer.The changes of diopter were analyzed and compared.Results In the group of 4-12 years old children,there was significant difference between Mydrin and atropine gutta in means of the spherical lens（P0.05）,but no difference in the mean of column lens or axis after Compound Tropicamide（P0.05）.Conclusion Mydrin can not replace atropine in optometry under the age of 12,but it can play an active role in the test of astigmatism and prevention of amblyopia.
出处
《西部医学》
2010年第9期1636-1637,共2页
Medical Journal of West China
关键词
屈光不正
儿童
复方托品卡胺
散瞳验光
Refraction error
Children
Compound tropeicamid
Mydriasis
